Since publication of the American Association of Physicists in Medicine (AAPM) Task Group No. 43 Report in 1995 (TG-43), both the utilization of permanent source implantation and the number of low-energy interstitial brachytherapy source models commercially available have dramatically increased. In addition, the National Institute of Standards and Technology has introduced a new primary standar...

Introduction: The commercial 252Cf sources are too large in size and clinical applications of neutron brachytherapy (NBT) are limited to a small number of intracavitary treatments of cervical cancers. Recently, under the Cooperative Research and Development Agreement (CRADA) with Isotron Inc., the Oak Ridge National Laboratory (ORNL) encapsulated a new medical 252Cf sources, c...

Higher initial dose rate and simplifying HDR room treatment of 169Yb element among other brachytherapy sources has led to investigating its feasibility as high-dose-rate seed. In this work, Monte Carlo calculation was performed to obtain dosimetric parameters of 169Yb, Model M42 source at different radial distances according to AAPM TG-43U1 and HEBD Report about HDR sources in both air vacuum a...

Brachytherapy treatment planning systems (BTPS) are employing the American Association of Physicists in Medicine (AAPM) Task Group 43 (TG-43)-recommended dosimetric parameters of sources, which are measured in water. The majority of brachytherapy implant volumes are not homogeneous media. Particularly, an implant with multiple seeds significantly changes homogeneity of the implant volume. Heter...

PURPOSE The clinical use of brachytherapy sources requires the existence of dosimetric data with enough of quality for the proper application of treatments in clinical practice. It has been found that the published data for the low dose rate CSM11 Cs-137 source lacks of smoothness in some regions because the data are too noisy. The purpose of this study was to calculate the dosimetric data for ...

INTRODUCTION The use of high-dose-rate brachytherapy is currently a widespread practice worldwide. The most common isotope source is 192Ir, but 60Co is also becoming available for HDR. One of main advantages of 60Co compared to 192Ir is the economic and practical benefit because of its longer half-live, which is 5.27 years. Recently, Eckert & Ziegler BEBIG, Germany, introduced a new afterloadin...

 Introduction:The commercial 252Cf sources are too large in size and clinical applications of neutronbrachytherapy (NBT) are limited to a small number of intracavitary treatments of cervical cancers. Recently, under the Cooperative Research and Development Agreement (CRADA) with Isotron Inc., the Oak Ridge National Laboratory (ORNL) encapsulated a new medical 252Cf sources, cal...